11 styczeń
Biznes i finanse
SOPHARMA AD (3/2023) Sales revenues for December 2022
- zp20
- Sopharma AD-BG11SOSOBT18-SOPHARMA
- 0 Komentarze
Podstawa prawna: art. 56. 1. 2 of Act on Public Offering.
“Sopharma” AD (the Company) notifies that for December 2022 the Company recorded an increase in sales of 19% compared to the same month of the previous year, incl. 14% increase in domestic sales and 21% increase in export sales.
Więcej na: http://biznes.pap.pl/pl/reports/espi/all,0,0,0,1
kom espi zdz
Pochodzenie informacji: pap-mediaroom.pl
Related Posts
